Category: by reason for retraction

1st retraction for researcher who lost whistleblower lawsuit

microvascular-research

A researcher who was dismissed from Wayne State University — then lost a whistleblower lawsuit against it — has logged his first retraction.

In 2012, after Christian Kreipke was dismissed from Wayne State, he filed a lawsuit, alleging that the institution had defrauded the U.S. government of $169 million in research funding. A judge dismissed the case in 2014, noting Kreipke cited “no specific facts,” and as a public university, Wayne State had immunity as an “arm of the state.”

The university’s president has said Kreipke was fired due to misconduct — not his whistleblowing, according to Courthouse News Service. 

Now, a retraction has appeared for Kreipke in Microvascular Research, citing discrepancies between the original data and what was reported in the paper. 

Here’s the retraction notice: Continue reading 1st retraction for researcher who lost whistleblower lawsuit

Cell Press won’t retract papers despite one author confessing to fraud

Screen Shot 2016-08-03 at 18.54.35Cell Press journals will not be retracting two papers that were flagged with expressions of concern (EOCs) in April after one author claimed to have manipulated some experiments.

In a strange turn of events, as we previously reported, the study’s corresponding author refuted the claims of the author who confessed to fraud, citing concerns about his “motives and credibility.” Since then, two independent labs repeated the authors’ experiments, and “largely confirm” the central conclusions of a Cell paper, but were inconclusive regarding a paper in Molecular Cell. Regardless, in both cases, the journals have decided to take no further action. 

Both expressions of concern (and their associated editorial notes) will remain online, as part of the “permanent record,” a Cell Press spokesperson told us.

The spokesperson added more about the investigation process: Continue reading Cell Press won’t retract papers despite one author confessing to fraud

Say what? Journal charges fee to lodge allegations against papers

erintHere’s something we haven’t seen before: A journal is asking tipsters to pay a fee to investigate a paper.

After receiving a tip of our own about this new requirement, we reached out to Educational Research International, and received this response: Continue reading Say what? Journal charges fee to lodge allegations against papers

Yes, “power pose” study is flawed, but shouldn’t be retracted, says one author

psychological-scienceAfter the first author of a debated study about the benefits of positioning your body in an assertive ways — the so-called “power pose” — posted her concerns about the research, she has told us she does not believe the paper should be retracted.

As reported by New York magazine, late last night, the first author of a 2010 paper in Psychological Science posted a statement saying she no longer believes the effects of the “power pose” are real.

We contacted Dana Carney, now based at the University of California, Berkeley, to ask if she thought the next step would be to retract the paper. She told us: Continue reading Yes, “power pose” study is flawed, but shouldn’t be retracted, says one author

Data were “fraudulently obtained” in epilepsy paper, probe finds

brain-research-bulletinA brain research journal has retracted a 2016 study about epilepsy after an institutional investigation determined that some of the data were taken from another published paper.

The retraction notice for the study — which appeared in Brain Research Bulletin — cites an investigation by the scientific integrity committee at Tongji University in Shanghai, China, which concluded the authors had engaged in “unethical publishing behavior.”

Here’s the retraction notice for “Clc-2 knockout attenuated experimental temporal lobe epilepsy in mice by tonic inhibition mediated by GABAA receptors:” Continue reading Data were “fraudulently obtained” in epilepsy paper, probe finds

Error in one line of code sinks cancer study

journl-of-clinical-oncologyAuthors of a 2016 cancer paper have retracted it after finding an error in one line of code in the program used to calculate some of the results.

Sarah Darby, last author of the now-retracted paper from the University of Oxford, UK, told Retraction Watch that the mistake was made by a doctoral student. When the error was realized, Darby said, she contacted the Journal of Clinical Oncology (JCO), explained the issue, and asked whether they would prefer a retraction or a correction. JCO wanted a retraction, and she complied.

The journal allowed the authors to publish a correspondence article outlining their new results.

Here’s the lengthy retraction notice, published online last month: Continue reading Error in one line of code sinks cancer study

Authors retract two papers on shock therapy, citing language barriers

the-journal-of-ectAn electroconvulsive therapy (ECT) journal has retracted two 2016 papers after uncovering problems in the data analyses, which the author says were due to language barriers.

Interestingly, two authors of the newly retracted papers — Yu-Tao Xiang from the University of Macau in China and Gabor Ungvari from the University of Western Australia — also recently co-authored another paper on an entirely different topic that has received a lengthy correction. That paper — on the use of organs from executed prisoners in China — raised controversy for allegedly reporting a “sanitized” account of the practice. The correction notice, in the Journal of Medical Ethics, was accompanied by a critics’ rebuttal to the paper.

According to Xiang, the newly retracted papers in The Journal of ECT — which examined the efficacy of ECT in treating schizophrenia — were pulled due to “genuine errors” resulting from differences in language. All the authors agree with the retraction, Xiang noted. 

Xiang told us: Continue reading Authors retract two papers on shock therapy, citing language barriers

Author asks to retract nearly 20-year old paper over figure questions, lack of data

journal-of-biological-chemistryThe last author of a 1999 paper has asked the journal to retract it less than one month after a user raised questions about images on PubPeer.

Yesterday, last author Jim Woodgett posted a note on the site saying the author who generated the figures in question could not find the original data, and since he agreed the images appeared “suspicious,” he had contacted the journal to retract the paper.

Here’s the note from Woodgett, based at Lunenfeld-Tanenbaum
Research Institute at Mount Sinai Hospital in Toronto: Continue reading Author asks to retract nearly 20-year old paper over figure questions, lack of data

Finnish institute finds no evidence to support misconduct in diabetes paper

VTT Research CentreAn investigation at the VTT Technical Research Centre of Finland has found no evidence of misconduct by one of its former researchers in a diabetes paper.

We previously reported on the case after the VTT was accused of cutting corners in a previous investigation into Matej Orešič (now based at the Steno Diabetes Center in Gentofte, Denmark). In 2014, the VTT concluded that there was no evidence of falsification or data tampering on the part of Orešič in the 2008 paper published in the Journal of Experimental Medicine (JEM). The proceedings came into the public domain through a news article published in the Finnish media outlet Helsingin Sanomat in February 2016, which prompted the VTT to reopen the case.

Now, the same people who questioned the previous investigation told us they have doubts about the latest conclusions, noting the probe should not have focused on a single paper, but rather on alleged problems within the plasma and serum metabolomics group, previously led by Orešič.

Orešič sent us this report, which the VTT released on June 15, outlining their decision. The VTT confirmed the legitimacy of the report, which says: Continue reading Finnish institute finds no evidence to support misconduct in diabetes paper

Doctor who participated in fake chocolate study fined for violating code of conduct

Source: AKA
Source: AKA

A German district attorney has fined a doctor who participated in a bogus study showing chocolate helps weight loss, designed to illustrate how shady science can make the news, arguing it was unethical to ask people to participate unknowingly in such a scam.

As soon as the study was published, critics raised questions over whether it was appropriate to include volunteers in a bogus clinical trial, which included giving blood. Recently, a German district attorney for professional conduct of physicians ruled that it was not.

In an anonymized version of a decision from the district attorney – who investigates on possible violations of the physicians’ professional law – he fined the doctor who participated in a bogus study about the health benefits of chocolate 500 Euros for not obtaining proper consent from the people who volunteered to participate, and for not involving an ethics committee. Continue reading Doctor who participated in fake chocolate study fined for violating code of conduct